APOPTOSIS - A MARKET INSIGHT REPORT

Table of Contents

I. SCOPE AND METHODOLOGY

II. REPORT SYNOPSIS

1. Foreword

• Apoptosis
  • Segmentation of Apoptosis
    • Exhibit 1: Segmentation of Global Apoptosis Related Products Market by apoptosis molecular pathways (Caspases, Protease Inhibitors, Bcl-2 Modulators, p53 Modulators and Other) and Therapeutic Areas (Cancer, Neurodegenerative Diseases, Cardiovascular Diseases and Other)

2. Global Market Analysis

• Exhibit 2: Apoptosis Related Products (2005-2012) - Global Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)
  • Analysis of Apoptosis Related Products by Molecular Pathways
    • Caspases
      • Exhibit 3: Caspase Activators and Inhibitors (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for United States, Europe, Japan and Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 4: Caspase Activators and Inhibitors (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for United States, Europe, Japan and Rest of World
    • Protease Inhibitors
      • Exhibit 5: Protease Inhibitors (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for United States, Europe, Japan and Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 6: Protease Inhibitors (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for United States, Europe, Japan and Rest of World (Graphical Representation Included)
    • Bcl-2 Modulators
      • The Role of Bcl-2 in Diseases
      • Exhibit 7: Bcl-2 Modulators (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for United States, Europe, Japan and Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 8: Bcl-2 Modulators (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for United States, Europe, Japan and Rest of World (Graphical Representation Included)
    • p53 Modulators
      • Exhibit 9: p53 Modulators (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for United States, Europe, Japan and Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 10: p53 Modulators (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for United States, Europe, Japan and Rest of World (Graphical Representation Included)
    • Other
      • Exhibit 11: Other Molecular Pathways of Apoptosis (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for United States, Europe, Japan and Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 12: Other Molecular Pathways of Apoptosis (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for United States, Europe, Japan and Rest of World (Graphical Representation Included)
  • Analysis of Apoptosis Related Products by Therapeutic Area
    • Cancer
      • Role of Apoptosis Proteins and Genes in Cancer
        • Bcl-2 Modulators
        • IAPs
      • Exhibit 13: Apoptosis Related Therapeutic Products for Cancer (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for United States, Europe, Japan and Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 14: Apoptosis Related Therapeutic Products for Cancer (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for United States, Europe, Japan and Rest of World (Graphical Representation Included)
    • Neurodegenerative Diseases
      • Exhibit 15: Apoptosis Related Therapeutic Products for Neurodegenerative Diseases (2005- 2011) - Global Market Analysis (Current & Future) by Geographic Region for United States, Europe, Japan and Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 16: Apoptosis Related Therapeutic Products for Neurodegenerative Diseases (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for United States, Europe, Japan and Rest of World
    • Cardiovascular Diseases
      • Exhibit 17: Apoptosis Related Therapeutic Products for Cardiovascular Diseases (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for United States, Europe, Japan and Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 18: Apoptosis Related Therapeutic Products for Cardiovascular Diseases (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for United States, Europe, Japan and Rest of World
    • Other
      • Exhibit 19: Therapeutic Products for Other Apoptosis Based Diseases (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for United States, Europe, Japan and Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 20: Therapeutic Products for Other Apoptosis Based Diseases (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for United States, Europe, Japan and Rest of World
      • Exhibit 21: List of Major Global Companies

3. Regional Market Analysis

• The United States
  • Exhibit 22: Apoptosis Related Products (2005-2012) - United States Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)
  • A Glance at Major Companies in the United States
    • A.G. Scientific
    • Abbott Laboratories
    • Alexion Pharmaceuticals
    • Alfacell Corporation
    • Amgen
    • Applied Molecular Evolution
    • Ariad Pharmaceuticals
    • ArQule
    • AVI BioPharma
    • BD Biosciences
    • Cyclacel Pharmaceuticals
    • Dendreon Corporation
    • EntreMed
    • EpiCept Corporation
    • Genta, Inc
    • Genzyme Corporation
    • Human Genome Sciences
    • Incyte Corporation
    • Introgen Therapeutics, Inc
    • ISIS Pharmaceuticals
    • Keryx Biopharmaceuticals
    • MGI Pharma
    • Millennium Pharmaceuticals
    • North American Scientific
    • Onyx Pharmaceuticals
    • OSI Pharmaceuticals
    • Pfizer
    • Pharmacyclics
    • Schering-Plough
    • Senesco Technologies
    • Sigma-Aldrich Corporation
    • Telik, Inc
    • Vertex Pharmaceuticals
    • Titan Pharmaceuticals
• Europe
  • Exhibit 23: Apoptosis Related Products (2005-2012) - European Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)
  • A Glance at Major Companies in Europe
    • Antisoma plc (UK)
    • F.Hoffmann-La Roche Ltd. (Switzerland)
    • Miltenyi Biotec GmbH
    • Novartis AG (Switzerland)
    • Zentaris GmbH (Germany)
• Japan
  • Exhibit 24: Apoptosis Related Products (2005-2012) - Japanese Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)
  • Takeda Pharmaceutical Co., Ltd. - A Major Market Player
• Rest of World
  • Exhibit 25: Apoptosis Related Products (2005-2012) - Rest of World Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)
  • A Glance at Major Companies in Rest of World Region
    • Aegera Therapeutics, Inc. (Canada)
    • Aida Pharmaceuticals, Inc. (China)
    • D-Pharm Ltd. (Israel)
    • Novogen Limited (Australia)
    • Vasogen, Inc. (Canada)

III. PRODUCT RESEARCH

1. Introduction

• Apoptosis - The Major Form of Programmed Cell Death
  • Global Growth Trends - Apoptosis Related Therapeutic Products
    • Exhibit 26: Global Market for Apoptosis Related Therapeutic Products: Geographic Regions (United States, Japan and Europe) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)
  • The Process of Apoptosis
    • Cell Death Due to Injury
    • Cell Death Due to Suicide
      • Reasons for Cell Suicide
  • Procedures for Apoptosis Identification
    • The ISEL technique
    • TUNEL technique
    • Methods for Understanding Apoptosis
      • DNA Fragmentation to Aid Apoptosis Measurement
      • Measurement of Variations in Apoptosis by Cdk2
      • Apoptotic Cell Clearance Measurement In Vitro
      • Exploring Apoptosis in Drosophila' s

2. Apoptosis Molecular Pathways

• Growth Trends - Global Apoptosis Related Therapeutic Products by Molecular Pathways
  • Exhibit 27: Global Market for Apoptosis Related Therapeutic Products: Apoptosis Molecular Therapeutics (Bcl-2 Modulators, p53 Modulators, Caspases and Protease Inhibitors) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)
• Key Molecular Pathways of Apoptosis
  • Caspases
  • Growth Trends - Global Market for Caspase Activators and Inhibitors
    • Exhibit 28: Global Market for Caspase Activators and Inhibitors: Geographic Regions (United States, Japan and Europe) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)
  • Types of Caspase Proteins
    • Initiator Caspases
    • Effector Caspases
  • The Caspase Flow
    • Function of Caspases in Apoptosis, Development and Cytokine Maturation
    • Card Domains
  • Protease Inhibitors
    • Growth Trends - Global Market for Protease Inhibitors
      • Exhibit 29: Global Market for Protease Inhibitors: Geographic Regions (Japan, Europe and United States) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)
  • Bcl-2 Modulators
    • Growth Trends - Global Market for Bcl-2 Modulators
      • Exhibit 30: Global Market for Bcl-2 Modulators: Geographic Regions (United States, Japan and Europe) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)
    • Structure of Bcl-2 Family
    • The Role of Bcl-2 in Diseases
    • Biochemical Properties of Bcl-2 Proteins
    • Cytoplasmic Proteins
  • p53 Modulators
    • Growth Trends - Global Market for p53 Modulators
      • Exhibit 31: Global Market for p53 Modulators: Geographic Regions (United States, Japan and Europe) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)
  • Other Apoptosis Molecular Pathways
    • Inhibitors of Apoptosis Proteins
      • Identification of IAP Gene Family Proteins
    • TRAIL
    • MLK Inhibitor
    • Factor 5A
    • Protein Kinase Pathway Modulators
      • Chemotherapeutic Role of Telcyta in Various Cancers
    • Nicotinic Acetylcholine Receptor Agonist
    • HSP27

3. Disease Areas Connected with Apoptosis

• Growth Trends - Global Market for Apoptosis Therapeutic Areas
  • Exhibit 32: Global Market for Apoptosis Therapeutic Products: Major Apoptosis Related Therapeutic Areas (Neurodegenerative Diseases, Cardiovascular Diseases and Cancer) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)
  • Cancer
    • Major Companies in Global Cancer Market
      • Exhibit 33: Global Market for Cancer Therapeutic Products (2005 & 2006): Percentage Breakdown of Market Share for Top 10 Companies - Roche, Sanfo-Aventis, Amgen, Astra-Zeneca, Novartis, Johnson & Johnson, Bristol-Myer Squibb, Schering-Plough, Pfizer, Eily-Lilly (Graphical Representation Included)
    • Growth Trends - Global Market for Apoptosis Related Therapeutic Products for Cancer
      • Exhibit 34: Global Market for Apoptosis Related Therapeutic Products for Cancer: Geographic Regions (Japan, United States and Europe) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)
  • Neurodegenerative Disease
    • Growth Trends - Global Market for Apoptosis Related Therapeutic Products for Neurodegenerative Disease
      • Exhibit 35: Global Market for Apoptosis Related Therapeutic Products for Neurodegenerative Disease: Geographic Regions (United States, Japan and Europe) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)
    • Alzheimer' s
      • Importance of Apoptosis in Alzheimer' s Disease
      • Familial Alzheimer' s Disease and Role Of Mutant APP
    • Parkinson' s
      • Function of Apoptosis in PD and Symptoms of Neuronal Degradation
      • Apoptosis in Parkinson' s Disease and Nigral Neuronal Death
      • Potential Markers of Apoptosis in Parkinson' s Disease
    • Rheumatoid Arthritis
      • Role of Apoptosis in Rheumatoid Arthritis Synovium
    • Multiple Sclerosis
      • The Diagnosis of MS
      • Functioning of Oligodendrocytes Apoptosis in MS and EAE
  • Cardiovascular Diseases - Role of Cell Apoptosis
    • Growth Trends - Global Market for Apoptosis Related Therapeutic Products for Cardiovascular Disease
      • Exhibit 36: Global Market for Apoptosis Related Therapeutic Products for Cardiovascular Disease: Geographic Regions (United States, Japan and Europe) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)
  • Other Apoptosis Based Diseases
    • Organ Transplant Rejection
    • Types of Organ Rejection
      • Hyperacute Rejection
      • Acute Rejection
      • Chronic Rejection
      • Treating Rejection
    • HIV Infection
    • Sepsis and Multiple Organ Dysfunction Syndrome
      • Requirement of Logical Strategies
      • Sepsis Controlled by Apoptosis

4. Apoptosis Therapeutics

• Technologies Involved in Drug Making Process for Apoptosis Based Treatment
  • Target Discovery and Validation
    • Structural Biology
  • Drug Candidate Identification
    • Antisense
      • Types of Antisense
        • The nbl Antisense
        • Antisense CK2
      • Np73 Antisense
        • Np73 Function in SH-SY5Y Neuroblastoma Cells
    • Small Molecule Mimetics
  • Drug Discovery
    • Combinatorial Chemistry
    • High Throughput Screening
• Analysis of Apoptosis Based Drugs - Listed by Molecular Pathways
  • Caspases
    • Executioner Caspases
      • CASPASE-8
      • Caspase-3
    • IDN-6556
      • Application of IDN-6556 for Human Liver Preservation Injury
    • MX1122
    • MX1013
  • Protease Inhibitors
    • VELCADE™ (BORTEZOMIB)
  • Bcl-2 Modulators
    • Genase
      • Genasense in combination with chemotherapy
      • Genasense: Positive effects On Bladder Tumor
    • HA14-1
  • p53 Modulators
    • SCH58500
    • INGN 241
      • INGN 241 in combination with Introgen
      • Administration of INGN 241 with Herceptin
    • INGN 251
    • ONYX-015
  • Apoptosis Related Products in Developments
    • The Combination of Apoptosis with Anti-Angiogenesis Yields Better Results
    • Personalized Cancer Therapy with Caspase-3
    • Exhibit 37: Some of the Apoptosis Related Products in Development

IV. MARKET DYNAMICS

1. Market Overview

• Global Market Analysis
  • Exhibit 38: Apoptosis Related Products (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for United States, Europe, Japan and Rest of World in US$ Million (Graphical Representation Included)
  • Exhibit 39: Apoptosis Related Products (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for United States, Europe, Japan and Rest of World (Graphical Representation Included)

2. Major Companies in Apoptosis Market

• A.G. Scientific, Inc. (USA)
• Abbott Laboratories (USA)
• Aegera Therapeutics, Inc. (Canada)
• Aida Pharmaceuticals, Inc. (China)
• Alexion Pharmaceuticals, Inc. (USA)
• Alfacell Corporation (USA)
• Amgen, Inc. (USA)
• Antisoma plc (UK)
• Applied Molecular Evolution (USA)
• Ariad Pharmaceuticals, Inc. (USA)
• ArQule, Inc (USA)
• AVI BioPharma Inc. (USA)
• BD Biosciences (USA)
• Cyclacel Pharmaceuticals, Inc. (USA)
• Dendreon Corporation (USA)
• D-Pharm Ltd. (Israel)
• EntreMed, Inc. (USA)
• EpiCept Corporation (USA)
• F.Hoffmann-La Roche Ltd. (Switzerland)
• Genta, Inc. (USA)
• Genzyme Corporation (USA)
• Incyte Corporation (USA)
• Introgen Therapeutics, Inc. (USA)
• Invitrogen, Inc. (USA)
• ISIS Pharmaceuticals, Inc. (USA)
• MGI Pharma, Inc. (USA)
• Millennium Pharmaceuticals Inc. (USA)
• Miltenyi Biotec GmbH
• Novartis AG (Switzerland)
• Novogen Limited (Australia)
• Onyx Pharmaceuticals, Inc. (USA)
• OSI Pharmaceuticals, Inc. (USA)
• Pfizer, Inc. (USA)
• Pharmacyclics, Inc. (USA)
• Schering-Plough Corporation (USA)
• Sigma-Aldrich Corporation (USA)
• Takeda Pharmaceutical Co., Ltd. (Japan)
• Titan Pharmaceuticals, Inc. (USA)
• Vasogen, Inc. (Canada)
• Vertex Pharmaceuticals, Inc. (USA)
• Zentaris GmbH (Germany)

3. Recent Activities in Apoptosis Market

• EntreMed Announces Results for ENMD-1198 and Vincristine in Pre-clinical Leukemia Models
• Arius Signs Agreement with Avid Bioservices for CD44 Cancer Stem Cell Antibody
• EntreMed Starts Phase II Study with MKC-1 to Treat Pancreatic Cancer
• AnaSpec Launches Bcl Peptides
• BioLineRx Acquires the Anti-Cancer Compound BL-4060
• Phase II Multi-Center Clinical Trial Enrollment for NSCLC Completed
• Cell Signaling Technology Offers PhosphoScan® Profiling Technology and PhosphoSite® Knowledgebase to Academic Researchers
• Cambridge Antibody Technology Merges into MedImmune
• Human Genome Sciences Shows Anti-Tumor Activity and Efficacy of TRAIL Receptor Antibodies When Combined with Chemotherapy
• ImClone and Bristol-Myers Squibb Form an Agreement with Merck KGaA to Jointly Develop and Commercialize ERBITUX® in Japan
• Cyclacel Pharmaceuticals Buys Specialty Pharmaceutical Business Focused on the Oncology Market
• EpiCept Successfully Completes Phase I Trial for EPC2407 in Apoptosis Induction
• Aegera Therapeutics Acquires LymphoSign Inc and Closes Concurrent Financing
• Genentech Purchases Stake in Tanox
• Cell Signaling Technology, Inc. Increases its PhosphoScan® Patent Portfolio
• TopoTarget Acquires Apoxis SA
• Myriad Genetics and AstraZeneca Collaborate on New Treatment for BRCA1 & BRCA2 Mutations
• Azixa™ of Myriad Genetics in Phase II for Brain Cancer
• Takeda Pharmaceuticals and CanBas in Collaboration for Cancer Treatment
• BD Biosciences Collaborates with Roche to Accelerate the Study of Cell Signal Transduction Using New Phosphorylation Site Antibody Targets and Applications
• MMRC Joins Hands with Keryx
• EpiCept' s EPC2407 Well Suited for Lymphomas and Advanced Stage in Cancer
• Gemin X Undertakes Further Research on GX15-070
• XOMA Ties-up with Takeda
• TorreyPines Therapeutics Merges with Axonyx
• Aida Acquires Qiaer Bio-Technology
• Enzon and Santaris in Collaboration for a Series of RNA Antagonists
• Millipore Acquires Serologicals Corp.
• Stressgen Assumes New Corporate Identity
• Sigma-Aldrich Launches PanoramaTM
• CST Signs Pact with AstraZeneca
• Takeda Enters into Partnership with Arius
• EpiCept Joins Hands with Maxim
• Targacept Signs Partnership and Licensing Agreement with AstraZeneca
• Apoxis Enters into Deal with Astellas Pharma
• PIramed Enters into Alliances with Genentech
• Invitrogen Takes Over BioSource International
• MedImmune Signs Agreement with VasGene
• Nanocure Adopts New Corporate Identity
• Pfizer Inc., Acquires Idun Pharmaceuticals
• AXXORA Merges with APOTECH
• Invitrogen Takes Over Zymed Laboratories
• B-Bridge Enters into Deal with RZPD

4. Regional Market Analysis

• A. The United States
  • Analysis by Apoptosis Molecular Pathways
    • Exhibit 40 Apoptosis Related Products (2005-2012) - United States Market Analysis (Current & Future) by Apoptosis Molecular Pathways for Caspases, Protease Inhibitors, Bcl-2 Modulators, p53 Modulators and Other in US$ Million (Graphical Representation Included)
    • Exhibit 41: Apoptosis Therapeutic Products (2006, 2009 and 2012) - Percentage Breakdown of United States Market Value by Apoptosis Molecular Pathways for Caspases, Protease Inhibitors, Bcl-2 Modulators, p53 Modulators and Other
  • Analysis by Therapeutic Area
    • Exhibit 42: Apoptosis Related Products (2005-2012) - United States Market Analysis (Current & Future) by Therapeutic Area for Cancer, Neurodegenerative, Cardiovascular and Other in US$ Million (Graphical Representation Included)
    • Exhibit 43: Apoptosis Related Products (2006, 2009 and 2012) - Percentage Breakdown of United States Market Value by Therapeutic Area for Cancer, Neurodegenerative, Cardiovascular and Other
    • Exhibit 44: List of Major Companies in the United States
• B. Europe
  • Analysis by Geographic Region
    • Exhibit 45: Apoptosis Related Products (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France and Rest of Western Europe in US$ Million (Graphical Representation Included)
    • Exhibit 46: Apoptosis Related Products (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, France and Rest of Western Europe
  • Analysis by Apoptosis Molecular Pathways
    • Exhibit 47: Apoptosis Related Products (2005-2012) - European Market Analysis (Current & Future) by Apoptosis Molecular Pathways for Caspases, Protease Inhibitors, Bcl-2 Modulators, p53 Modulators and Other in US$ Million (Graphical Representation Included)
    • Exhibit 48: Apoptosis Therapeutic Products (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Apoptosis Molecular Pathways for Caspases, Protease Inhibitors, Bcl-2 Modulators, p53 Modulators and Other
  • Analysis by Therapeutic Area
    • Exhibit 49: Apoptosis Related Products (2005-2012) - European Market Analysis (Current & Future) by Therapeutic Area for Cancer, Neurodegenerative, Cardiovascular and Other in US$ Million (Graphical Representation Included)
    • Exhibit 50: Apoptosis Related Products (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Therapeutic Area for Cancer, Neurodegenerative, Cardiovascular and Other
    • Exhibit 51: List of Major Companies in the Europe
• C. Japan
  • Analysis by Apoptosis Molecular Pathways
    • Exhibit 52: Apoptosis Related Products (2005-2012) - Japanese Market Analysis (Current & Future) by Apoptosis Molecular Pathways for Caspases, Protease Inhibitors, Bcl-2 Modulators, p53 Modulators and Other in US$ Million (Graphical Representation Included)
    • Exhibit 53: Apoptosis Therapeutic Products (2006, 2009 and 2012) - Percentage Breakdown of Japanese Market Value by Apoptosis Molecular Pathways for Caspases, Protease Inhibitors, Bcl-2 Modulators, p53 Modulators and Other
  • Analysis by Therapeutic Area
    • Exhibit 54: Apoptosis Related Products (2005-2012) - Japanese Market Analysis (Current & Future) by Therapeutic Area for Cancer, Neurodegenerative, Cardiovascular and Other in US$ Million (Graphical Representation Included)
    • Exhibit 55: Apoptosis Related Products (2006, 2009 and 2012)- Percentage Breakdown of Japanese Market Value by Therapeutic Area for Cancer, Neurodegenerative, Cardiovascular and Other (Graphical Representation Included)
    • Exhibit 56: List of Major Companies in Japan
• D. Rest of World
  • Analysis by Apoptosis Molecular Pathways
    • Exhibit 57: Apoptosis Related Products (2005-2012) - Rest of World Market Analysis (Current & Future) by Apoptosis Molecular Pathways for Caspases, Protease Inhibitors, Bcl-2 Modulators, p53 Modulators and Other in US$ Million (Graphical Representation Included)
    • Exhibit 58: Apoptosis Therapeutic Products (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Apoptosis Molecular Pathways for Caspases, Protease Inhibitors, Bcl-2 Modulators, p53 Modulators and Other
  • Analysis by Therapeutic Area
    • Exhibit 59: Apoptosis Related Products (2005-2012) - Rest of World Market Analysis (Current & Future) by Therapeutic Area for Cancer, Neurodegenerative, Cardiovascular and Other in US$ Million (Graphical Representation Included)
    • Exhibit 60: Apoptosis Related Products (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Therapeutic Area for Cancer, Neurodegenerative, Cardiovascular and Other
    • Exhibit 61: List of Major Companies in Rest of World

5. The Market Outlook

V. CORPORATE DIRECTORY